Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pectin in Adults With Crohn's Disease
NCT02164877Phase 2Terminated
- Sponsor
- Jinling Hospital
- Start
- Jun 2014
- Primary completion
- May 2017
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Crohn's disease, sponsored by Jinling Hospital. Primary endpoint: Bacterial translocation in MLN, mesenteric fat and peripheral blood at 4 weeks. Started Jun 2014; status: terminated.
02
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02164877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02164877.